BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on COSOPT-S® 20 mg/ml and 5 mg/ml eye drops in single-dose containers: Risk of eye injury

Active substance: dorzolamide hydrochloride

The company MSD Sharp & Dohme GmbH is circulating information on changes in the design of the product resulting in instructions for use to be observed in order to avoid eye injury.

(instruction for use - available in German only)

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 160KB, File is accessible